Combination Pharmacological Therapies for the Management of Benign Prostatic Hyperplasia

Author： Cohen Seth A. Parsons J. Kellogg

ISSN： 1170-229X

Source： Drugs & Aging, Vol.29, Iss.4, 2012-04, pp. : 275-284

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination Therapy for the Pharmacological Management of Benign Prostatic Hyperplasia: Rationale and Treatment Options

By Sandhu Jaspreet S.

Drugs & Aging, Vol. 22, Iss. 11, 2005-01 ,pp. : 901-912

Adis International

Access to resources Recommend Favorite

Current evidence supports the use of combination therapy in the management of benign prostatic hyperplasia

Drugs & Therapy Perspectives, Vol. 28, Iss. 12, 2012-12 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite

Emerging drug therapies for benign prostatic hyperplasia

By Bullock Travis L Andriole Jr Gerald L

Expert Opinion on Emerging Drugs, Vol. 11, Iss. 1, 2006-03 ,pp. : 111-123

Informa Healthcare

Access to resources Recommend Favorite

Investigational therapies targeted to the treatment of benign prostatic hyperplasia

By Gravas Stavros de la Rosette Jean JMCH

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 3, 2013-03 ,pp. : 357-368

Informa Healthcare

Access to resources Recommend Favorite

Combination of finasteride and doxazosin for the treatment of benign prostatic hyperplasia

By Doggrell Sheila A

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 5, 2004-05 ,pp. : 1209-1211

Informa Healthcare

Access to resources Recommend Favorite